Showing results (1631-1640 of 4,515) with videos related to
Sort By:
Pageof 452
Advances in Therapy|March 14, 2012
Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysisMachaon M K Bonafede, Shravanthi R Gandra, Crystal Watson, et al.Advances in Therapy|November 10, 2011
An overview of letrozole in postmenopausal women with hormone-responsive breast cancerAgustí Barnadas, Laura G Estévez, Ana Lluch-Hernández, et al.Advances in Therapy|July 2, 2017
Intracameral Dexamethasone Injection as Adjuvant Therapy in Endothelial Immune Reaction After Penetrating and Posterior Lamellar Keratoplasty: A Retrospective Clinical ObservationMiltiadis Fiorentzis, Arne Viestenz, Anja Viestenz, et al.Advances in Therapy|July 9, 2017
Prevalence of Lower Urinary Tract Symptoms in China, Taiwan, and South Korea: Results from a Cross-Sectional, Population-Based StudyChristopher Chapple, David Castro-Diaz, Yao-Chi Chuang, et al.Advances in Therapy|July 9, 2017
Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical TrialArrigo F G Cicero, Federica Fogacci, Marilisa Bove, et al.Advances in Therapy|July 11, 2018
Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient-Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish ContextMonika Wagner, Dima Samaha, Jesus Cuervo, et al.Advances in Therapy|August 2, 2018
Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler® for Patients with Poorly Controlled Obstructive Airway Disease: a Real-World Study of Patient-Reported OutcomesLilla Tamási, Maria Szilasi, Gabriella GálffyAdvances in Therapy|January 24, 2022
Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in JapanToru Nakazawa, Kanji Takahashi, Yasuaki Kuwayama, et al.Advances in Therapy|December 8, 1997
Therapeutic efficacy and safety of Cimicifuga racemosa for gynecologic disordersE LiskePageof 452